This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
- December 03, 2003
Targacept Announces Results Identifying Key Enzyme Involved in Cell Death - November 11, 2003
Targacept Presents Data on Multiple Drug Candidates at Society for Neuroscience 33rd Annual Meeting - October 30, 2003
Targacept Announces Positive Clinical Results for TC-1734 - September 22, 2003
Targacept Appoints Jeffrey Brennan as VP of Business and Commercial Development - September 10, 2003
Targacept Awarded NIST ATP Grant for Innovative Drug Discovery Research - June 19, 2003
Targacept Awarded SBIR Grant - March 19, 2003
Targacept Completes $60 Million Second Round Financing